SCHEMBL720460

SCHEMBL720460

CCOc1ccccc1C(=O)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.67
MEN1 O00255 1/20 0.61
KMT2A Q03164 1/20 0.61
ABCB1 P08183 4/20 0.59
LMNA P02545 2/20 0.59
HCRTR1 O43613 2/20 0.58
ELANE P08246 1/20 0.57
DRD2 P14416 1/20 0.56
DRD1 P21728 1/20 0.56
DRD3 P35462 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
GLA P06280 1/20 0.56
MAPT P10636 2/20 0.52
MRGPRX4 Q96LA9 1/20 0.51
GAA P10253 1/20 0.51
MAPK1 P28482 1/20 0.51
ALDH1A1 P00352 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30033997 1.00 RAB9A (0.67) RAB9AMEN1KMT2AABCB1LMNA
Hydrochloric Acid SCHEMBL8729799 0.98 RAB9A (0.65) RAB9AMEN1KMT2AABCB1LMNA
Bicarbonate SCHEMBL27740096 0.98 RAB9A (0.65) RAB9AMEN1KMT2AABCB1LMNA
SCHEMBL206583 0.89 HCRTR1 (0.66) RAB9AMEN1KMT2ALMNAHCRTR1
SCHEMBL9451170 0.88 RAB9A (0.58) RAB9AMEN1KMT2AABCB1LMNA
SCHEMBL7768349 0.88 ABCB1 (0.60) RAB9AMEN1KMT2AABCB1LMNA
SCHEMBL23175185 0.87 RAB9A (0.57) RAB9AMEN1KMT2AABCB1LMNA
SCHEMBL28426243 0.87 RAB9A (0.57) RAB9AMEN1KMT2AABCB1LMNA
SCHEMBL7386575 0.87 RAB9A (0.57) RAB9AMEN1KMT2AABCB1LMNA
SCHEMBL206584 0.87 RAB9A (0.57) RAB9AMEN1KMT2AABCB1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107318266-A Process for preparing (meth) acrylate group-containing benzophenones for optical adhesive use and optical adhesive composition 株式会社LG化学 2017-11-03 CN claimed
CN-102245180-A Compositions and methods for the treatment of altered alpha-synuclein function PARKINSON S INST 2011-11-16 CN claimed
WO-2010042728-A1 SMALL MOLECULE MODULATORS OF PRONGF UPTAKE CORNELL UNIVERSITY (US) 2010-04-15 WO claimed
US-12630654-B2 Emulsion particle-containing aqueous dispersion NIPPON SHOKUBAI CO., LTD. (JP) 2026-05-19 US disclosed
US-12590214-B2 Ink-jet ink NIPPON SHOKUBAI CO., LTD. (JP) 2026-03-31 US disclosed
US-12473456-B2 Aqueous dispersion, production method therefor, coating composition, and coating film NIPPON SHOKUBAI CO., LTD. (JP) 2025-11-18 US disclosed
CN-113645952-B Oily mixture composition, cosmetic, and method for producing cosmetic 信越化学工业株式会社 2025-05-02 CN disclosed
US-12084582-B2 Emulsion for water-based ink and ink composition for water-based ink containing the same NIPPON SHOKUBAI CO., LTD. (JP) 2024-09-10 US disclosed
WO-2024181338-A1 COMPOSITION CONTAINING CARBON MATERIAL 株式会社日本触媒 2024-09-06 WO disclosed
CN-118256177-A Composition for forming adhesive layer, laminate, method for producing adhesive layer, method for producing laminate, and method for treating laminate 日铁化学材料株式会社 2024-06-28 CN disclosed
CN-118255947-A (Meth) acrylic acid copolymer and method for producing same 日铁化学材料株式会社 2024-06-28 CN disclosed
EP-0912494-A1 COUMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES NPS PHARMACEUTICALS, INC. (US) 1999-05-06 EP disclosed
WO-1998056752-A1 COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES NPS PHARMACEUTICALS, INC. (US) 1998-12-17 WO disclosed
WO-1997046511-A1 COUMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES NPS PHARMACEUTICALS, INC. (US) 1997-12-11 WO disclosed
EP-0107654-A4 COATED SURFACE STABILIZED POLYCARBONATE ARTICLE. GEN ELECTRIC (US) 1984-08-10 EP disclosed
EP-0107654-A1 COATED SURFACE STABILIZED POLYCARBONATE ARTICLE. GEN ELECTRIC (US) 1984-05-09 EP disclosed
WO-1983003905-A1 COATED SURFACE STABILIZED POLYCARBONATE ARTICLE GENERAL ELECTRIC COMPANY (US) 1983-11-10 WO disclosed
EP-0076017-A2 Phenyl substituted pyrido(1,4)benzodiazepines and intermediates therefor A.H. ROBINS COMPANY, INCORPORATED (US) 1983-04-06 EP disclosed
US-4024324-A Novel polyolefin composition of matter UOP INC. (US) 1977-05-17 US disclosed
US-3992349-A Photodegradable polyolefin composition containing a mixture of an aryl ketone and an alkanolamine UOP INC. (US) 1976-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630654-B2 Emulsion particle-containing aqueous dispersion CLTB, CLTA, APOB RAB9A 3880/4885MEN1 2464/4885KMT2A 1729/4885
US-12590214-B2 Ink-jet ink MIF, ELANE, SEM1 RAB9A 1507/4885MEN1 2888/4885KMT2A 3708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.